Search Results - "Percovich, Juan Carlos"
-
1
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
Published in European journal of nuclear medicine and molecular imaging (01-07-2023)“…Background Peptide receptor radionuclide therapy (PRRT) is one of the most promising therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless,…”
Get full text
Journal Article -
2
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
Published in Neuroendocrinology (2022)“…Somatostatin analogs (SSA) prolong progression-free survival (PFS) in patients with well-differentiated gastroenteropancreatic neuroendocrine neoplasms…”
Get more information
Journal Article -
3
Risk factors for intraoperative complications in pheochromocytomas
Published in Endocrine-related cancer (01-11-2021)“…We aimed to identify presurgical and surgical risk factors for intraoperative complications in patients with pheochromocytomas. A retrospective study of…”
Get full text
Journal Article -
4
Pheochromocytoma-induced acute pancreatitis: A rare presentation
Published in Endocrinología, diabetes y nutrición. (01-05-2024)Get full text
Journal Article -
5
A case of type 1 diabetes mellitus in a woman with Shwachman‐Diamond syndrome
Published in Practical diabetes (2011) (01-11-2021)“…Shwachman‐Diamond syndrome (SDS) is an autosomal recessive genetic disorder, consisting of neutropenia that may progress to bone marrow failure, skeletal…”
Get full text
Journal Article -
6
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Published in Endocrine-related cancer (01-07-2024)“…The objective of the study was to evaluate the efficacy of second-line therapies in patients with acromegaly caused by a growth hormone (GH) and prolactin…”
Get more information
Journal Article -
7
Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours
Published in Scientific reports (17-02-2022)“…The purpose of our study was to develop a predictive model to rule out pheochromocytoma among adrenal tumours, based on unenhanced computed tomography (CT)…”
Get full text
Journal Article -
8
PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
Published in Biomedicine & pharmacotherapy (01-02-2022)“…Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have emerged as a therapeutic option for patients with hypercholesterolemia who do not attain…”
Get full text
Journal Article -
9
Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)
Published in Endocrine Connections (01-06-2022)“…Objective To compare the presentation and evolution of primary aldosteronism (PA) in the elderly (≥65 years) and young patients (<65 years). Methods A…”
Get full text
Journal Article -
10
Ectopic Cushing’s syndrome: clinical, diagnostic, treatment and follow-up outcomes of 12 cases of lung ectopic ACTH
Published in Endocrinology, diabetes & metabolism case reports (01-04-2023)“…Summary Ectopic Cushing’s syndrome (ECS) is a rare disease associated with significant comorbidity. Among the causes of Cushing's syndrome, adrenocorticotropic…”
Get full text
Journal Article -
11
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Published in Journal of clinical oncology (01-10-2019)“…Somatostatin analogs (SSAs) are recommended for the first-line treatment of most patients with well-differentiated, gastroenteropancreatic (GEP) neuroendocrine…”
Get full text
Journal Article -
12
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
Published in European journal of nuclear medicine and molecular imaging (01-08-2022)“…Purpose NETTER-R aimed to determine the efficacy, safety and tolerability of 177 Lu-DOTATATE in patients with progressive, advanced pancreatic neuroendocrine…”
Get full text
Journal Article -
13
Efficacy and safety of 177 Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 4116 Background: Peptide receptor radionuclide therapy with 177 Lu-DOTATATE is indicated in somatostatin receptor (SSTR)-positive…”
Get full text
Journal Article -
14
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
Published in The journal of clinical endocrinology and metabolism (18-11-2024)“…Abstract Context Few data exist about the clinical course of acromegaly, surgical and medical outcomes in patients with GH- and prolactin cosecreting pituitary…”
Get full text
Journal Article -
15
Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response
Published in The journal of clinical endocrinology and metabolism (21-12-2023)“…Abstract Context Patients with obesity have an overactivated renin-angiotensin-aldosterone system (RAAS) that is associated with essential hypertension…”
Get full text
Journal Article -
16
Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score
Published in Journal of hypertension (01-12-2022)“…Purpose: To develop a predictive model of hypertension resolution after adrenalectomy in patients with primary aldosteronism (PA), based on their presurgical…”
Get full text
Journal Article -
17
Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)
Published in Endocrine (01-11-2022)“…Objective The aim of this study was to evaluate the rate of adrenal venous sampling (AVS) performance in patients with primary aldosteronism (PA), the main…”
Get full text
Journal Article -
18
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
Published in European journal of endocrinology (05-06-2024)“…The aim of this study is to compare the response to first-line medical treatment in treatment-naive acromegaly patients with pure growth hormone (GH)-secreting…”
Get full text
Journal Article -
19
Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score
Published in Journal of hypertension (24-08-2022)Get full text
Journal Article -
20
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register
Published in Endocrine (01-05-2024)“…Purpose To evaluate whether the clinical, biochemical and radiological features of patients with primary aldosteronism (PA) can predict both main subtypes of…”
Get full text
Journal Article